NEW ZEALAND: Fight against Botrytis eyes February listing
Botry-Zen, the company that owns the rights to a biological control preventing botrytis in grapevines, will attain a listing on the New Zealand stock exchange in February, it said. The company has already had to return around NZ$115m in over-subscriptions for the NZ$5m share issue. Botry-Zen's 166m shares were issued at 10c each but have been trading in the mid-20c range, until rising to their current level of 40c two weeks ago.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-drinks gives you the widest beverage market coverage.
Paid just-drinks members have unlimited access to all our exclusive content - including 15 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Olly Wehring, editor of just-drinks
- Comment - 'Craft' and the Danger of 'Romance Copy'
- Is A-B InBev/SABMiller 'Mega-Merger' Off?
- Sustainability: What Craft Teaches Multi-Nationals
- Pernod takes positives from China Cognac bounce
- Ethiopia competition to remain "intense" - Diageo
- Bacardi bags a Bourbon with Angel's Envy buy
- SPI Group 'disappointed' over Stolichnaya ruling
- Anheuser-Busch InBev lines up new chairman
- Craft is an 'abused' term - Pernod Ricard exec
- Bacardi Brown-Forman here to stay
- Global rum insights - market forecasts, product innovation and consumer trends research
- Global non-Scotch whiskies insights - market forecasts, product innovation and consumer trends research
- ALDI 2015: Radically transforming Anglo Saxon grocery markets
- Champagne: Less Than Bubbly
- Beer Market Insights Africa 2014